Centro di Riferimento Oncologico
In research, Centro di Riferimento Oncologico stands highest in Health Sciences (#2,587 of 9,902 worldwide) and Medicine (#2,419 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Oncology (Oncology is 13.8× its share of world research).
- World rank, 2022-now
- #11,793 of 22,385 · #8,743 all time
- Rank in Italy
- #241 of 475
- Research works
- 2.6k ▼ 12% vs 2018-21
- Citations
- 75k 28.6 per fractional work
- Top-10% rate
- 15.7% all institutions 10.0%
- vs its own fields
- 1.15× 1.00× is exactly expected
- Open access
- 36% world 40%
- International
- 24% world 18%
What is Centro di Riferimento Oncologico known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #2,587 of 9,902 | 17.0% | 169 | #3167 | |
| MedicineField | #2,419 of 8,541 | 17.0% | 163 | #2912 |
Each strip is that field's whole ranked pool, with the notch where Centro di Riferimento Oncologico sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Centro di Riferimento Oncologico work in?
In 2022-now, 67% of research at Centro di Riferimento Oncologico is in Health Sciences, 22% in Life Sciences. Its largest fields are Medicine (64%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (4%). It does 2.8× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 25 fields, with their numbers
- Health Sciences19266.7%
- Medicine18564.2%
- Health Professions31.2%
- Dentistry20.7%
- Nursing20.6%
- Life Sciences6422.3%
- Physical Sciences238.1%
- Engineering93.1%
- Chemistry51.8%
- Materials Science31.1%
- Physics and Astronomy20.7%
- Environmental Science20.7%
- Computer Science10.5%
- Mathematics10.2%
- Earth and Planetary Sciences00.1%
- Energy00.0%
- Chemical Engineering00.0%
- Social Sciences82.9%
What does Centro di Riferimento Oncologico specialise in?
Where its research is concentrated relative to its size: Oncology takes 13.8× the share of its output that it takes of world research.
- OncologySubfield · 44.5 works14×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.5×. Every wedge is a field page.
All 25 fields, with their numbers
- Immunology and Microbiology3.52×10 works
- Medicine3.34×185 works
- Biochemistry, Genetics and Molecular Biology3.21×49 works
- Pharmacology, Toxicology and Pharmaceutics1.69×2 works
- Dentistry1.42×2 works
- Nursing1.16×2 works
- Chemistry1.12×5 works
- Health Professions0.46×4 works
- Economics, Econometrics and Finance0.43×3 works
- Neuroscience0.41×2 works
- Physics and Astronomy0.33×2 works
- Materials Science0.30×3 works
- Psychology0.24×2 works
- Engineering0.20×9 works
- Mathematics0.16×0 works
- Environmental Science0.14×2 works
- Agricultural and Biological Sciences0.08×1 works
- Social Sciences0.08×3 works
- Computer Science0.07×2 works
- Earth and Planetary Sciences0.06×0 works
- Chemical Engineering0.04×0 works
- Arts and Humanities0.04×0 works
- Decision Sciences0.04×0 works
- Energy0.02×0 works
- Business, Management and Accounting0.02×0 works
- Immunology and Microbiology 3.5×
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 3.2×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Dentistry 1.4×
- Nursing 1.2×
- Chemistry 1.1×
- Health Professions 0.5×
- Economics, Econometrics and Finance 0.4×
- Neuroscience 0.4×
- Physics and Astronomy 0.3×
- Materials Science 0.3×
- Psychology 0.2×
- Engineering 0.2×
- Mathematics 0.2×
- Environmental Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
- Computer Science 0.1×
- Earth and Planetary Sciences 0.1×
- Chemical Engineering 0.0×
- Arts and Humanities 0.0×
- Decision Sciences 0.0×
- Energy 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Centro di Riferimento Oncologico?
Ranked on the quality score, Silvia Franceschi, Luigino Dal Maso and Jerry Polesel lead among researchers whose main affiliation is Centro di Riferimento Oncologico.
- 1
Silvia Franceschi
Italy · #44,693 worldwide 125k citations · 1,509 works
- 2
Luigino Dal Maso
Italy · #70,366 worldwide 29k citations · 514 works
- 3
Jerry Polesel
Italy · #118,935 worldwide 16k citations · 441 works
- 4
Milena Sabrina Nicoloso
Italy · #123,893 worldwide 9k citations · 154 works
- 5
Alessandra Bearz
Italy · #301,226 worldwide 16k citations · 318 works
- 6
Luigi De Marco
Italy · #360,135 worldwide 5.3k citations · 116 works
- 7
Roberta Maestro
Italy · #403,283 worldwide 13k citations · 259 works
- 8
Claudio Belluco
Italy · #493,891 worldwide 1.3k citations · 39 works
- 9
Diego Serraino
Italy · #511,837 worldwide 34k citations · 735 works
- 10
Maura Sonego
Italy · #734,836 worldwide 1.4k citations · 40 works
Which keywords describe research at Centro di Riferimento Oncologico?
By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Cancer, Prognostic Factors, Clinical Trials, Clinical Practice Guidelines, Rituximab, Targeted Therapy and Breast Cancer.
- Cetuximab
- Cell-Free DNA
- Hodgkin's Lymphoma
- Genetic Pathogenesis
- Genomic Instability
- Genomic Aberrations
- Metastatic Breast Cancer
- Molecular Profiling
- Gene Expression
- Neoadjuvant Therapy
- Precision Medicine
- PET Imaging
- Quality of Life
- Radiotherapy
- Metastasis
- Targeted Therapy
- Rituximab
- Clinical Trials
- Prognostic Factors
- Cancer
- Chemotherapy
- Epidemiology
- Inflammation
- Clinical Practice Guidelines
- Immunotherapy
- Breast Cancer
- Biomarkers
- Survival Analysis
- Tumor Microenvironment
- Cancer Therapy
- Lymphoma
- Molecular Subtypes
- Therapeutic Targets
- Gene Expression Profiling
- Chronic Lymphocytic Leukemia
- Cancer Incidence
- Classification
- Genomic Profiling
- Cancer Genomics
- Mutational Signatures
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy29▲ 14×21 topics
- Cancer22▲ 5.6×38 topics
- Epidemiology18▲ 1.54×67 topics
- Prognostic Factors17▲ 14×14 topics
- Inflammation16▲ 2.6×57 topics
- Clinical Trials15▲ 7.8×16 topics
- Clinical Practice Guidelines14▲ 9.0×12 topics
- Rituximab14▲ 34×4 topics
- Immunotherapy14▲ 6.8×16 topics
- Targeted Therapy14▲ 22×5 topics
- Breast Cancer13▲ 19×11 topics
- Metastasis12▲ 13×10 topics
- Biomarkers12▲ 6.0×13 topics
- Radiotherapy12▲ 11×12 topics
- Survival Analysis12▲ 15×6 topics
- Quality of Life11▲ 2.7×33 topics
- Tumor Microenvironment10▲ 8.1×8 topics
- PET Imaging10▲ 22×4 topics
- Cancer Therapy9▲ 5.7×16 topics
- Precision Medicine9▲ 6.3×7 topics
- Lymphoma9▲ 19×4 topics
- Neoadjuvant Therapy8▲ 12×5 topics
- Molecular Subtypes8▲ 33×3 topics
- Gene Expression8▲ 4.5×10 topics
- Therapeutic Targets8▲ 19×7 topics
- Molecular Profiling8▲ 29×3 topics
- Gene Expression Profiling8▲ 33×2 topics
- Metastatic Breast Cancer8▲ 44×2 topics
- Chronic Lymphocytic Leukemia7▲ 59×1 topic
- Genomic Aberrations7▲ 59×1 topic
- Cancer Incidence7▲ 18×4 topics
- Genomic Instability7▲ 22×3 topics
- Classification7▲ 5.2×2 topics
- Genetic Pathogenesis7▲ 44×1 topic
- Genomic Profiling7▲ 23×2 topics
- Hodgkin's Lymphoma7▲ 44×1 topic
- Cancer Genomics6▲ 31×1 topic
- Cell-Free DNA6▲ 23×2 topics
- Mutational Signatures6▲ 31×1 topic
- Cetuximab6▲ 25×2 topics
Which research topics does Centro di Riferimento Oncologico publish most on?
By volume in 2022-now: Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 7 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 7 works
- 3 Cancer Genomics and Diagnostics Cancer Research 6 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
- 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 5 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 7 Colorectal Cancer Treatments and Studies Oncology 4 works
- 8 Breast Cancer Treatment Studies Cancer Research 4 works
- 9 Ovarian cancer diagnosis and treatment Reproductive Medicine 4 works
- 10 Cancer Treatment and Pharmacology Oncology 3 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Centro di Riferimento Oncologico's research output changed?
Output in 2022-2025 was 12% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Centro di Riferimento Oncologico as a percentage of every work published that year, 0.0011% in 2024.
Fractional works of Centro di Riferimento Oncologico over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.1% in 2020.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Centro di Riferimento Oncologico. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
